Please provide your email address to receive an email when new articles are posted on . In the PIVOTAL trial, patients undergoing hemodialysis with ferritin concentration less than 400 µg/L and a ...

The researchers found that patients received a median monthly iron dose of 264 and 145mg in the high- and low-dose groups, respectively. HealthDay News — For patients undergoing maintenance ...

Patients on hemodialysis who received high-dose had similar rates of infection and rates of hospitalization for infection compared with those treated with low-dose IV iron, a secondary analysis of the ...

Use of erythropoiesis-stimulating agents decreased, while use of iron increased. Meta-analysis reveals no statistically significant increase in the risks of infection, cardiovascular events, ...

Until now, no other treatment has been shown to reduce heart attack risk in patients on dialysis. High-dose intravenous (IV) iron reduces the risk for acute myocardial infarction in patients receiving ...

Proactive treatment with high-dose intravenous (IV) iron reduces the risk for classic atherothrombotic myocardial infarction — a type 1 MI — in dialysis patients, an analysis of data from the PIVOTAL ...

A new paper in Cardiovascular Research, published by Oxford University Press, indicates that iron treatments may reduce heart attacks in patients experiencing kidney failure undergoing dialysis.

PRINCETON, N.J., July 16, 2021 /PRNewswire/ — Sandoz, a global leader in generic and biosimilar medicines, today announced the immediate US availability of generic Ferumoxytol, an intravenous medicine ...